SEC Form 4 · accession 0001547522-17-000019
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Brigham
Officer — President & CEO · Director
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 12:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive stock options (right to buy) | $5.84 | Feb 10, 2017 | A | 25,000 | A | Feb 10, 2020 | Feb 9, 2027 | Common Stock | 25,000 | 25,000 | D |